Sustained-Release Formulation for Extraction-Socket Pain Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a sustained release pharmaceutical formulation that can be easily applied to tooth extraction sockets without preparation, adheres to the wound, resists erosion, and delivers analgesics or anesthetics for pain management while promoting wound healing, without adverse interactions with blood or tissue toxicity, and maintains mechanical integrity during the healing process.
Innovation Solution
A pharmaceutical formulation comprising an active ingredient dispersed in a water-miscible and hygroscopic network-forming material, optionally with a hydrophobic component and a reinforcing member, which forms a cohesive matrix upon hydration, allowing controlled release of drugs like bupivacaine or NSAIDs for pain management and wound healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a sustained release pharmaceutical formulation is designed to maintain mechanical integrity and adhere to the extraction socket, then the formulation reliability is improved, but the formulation complexity increases
Solution Approach 1:
The formulation uses a composite matrix combining water-miscible network-forming material (such as gelatin or collagen) with hydrophobic components and reinforcing members. This composite structure provides both mechanical integrity for reliability and controlled drug release properties, while the synergistic combination of materials achieves the desired performance without excessive complexity
Solution Approach 2:
The formulation incorporates reinforcing members (such as fibers or particles) distributed within the matrix to provide localized mechanical strength and erosion resistance. This local reinforcement approach maintains overall formulation reliability while keeping the base matrix relatively simple, avoiding the need for an entirely complex formulation
2Duration of action of moving object
If the formulation is designed to deliver analgesics and anesthetics for sustained pain relief, then the duration of action is improved, but the formulation complexity increases
Solution Approach 1:
The formulation ensures continuous drug release by maintaining a stable matrix structure that gradually degrades and releases analgesics and anesthetics over an extended period. The water-miscible network-forming material provides a sustained release mechanism that maintains therapeutic levels without requiring multiple doses or complex delivery systems
Solution Approach 2:
The formulation controls the release rate by adjusting parameters such as the molecular weight, composition, and degradation characteristics of the network-forming material. By modifying these parameters, the formulation achieves sustained pain relief duration without incorporating complex release mechanisms or multiple drug delivery systems
3Object-affected harmful factors
If the formulation is designed to promote wound healing and avoid tissue toxicity, then the biocompatibility is improved, but the formulation complexity increases
Solution Approach 1:
The formulation employs biocompatible, biodegradable materials such as gelatin or collagen that are naturally metabolized by the body. These materials provide the necessary functional properties and then degrade harmlessly, eliminating the need for complex removal systems or long-term monitoring, thereby reducing formulation complexity while ensuring tissue safety
Solution Approach 2:
The formulation utilizes the natural degradation and absorption processes of the network-forming material to benefit wound healing. The controlled degradation releases drugs while the material itself serves as a temporary scaffold that promotes tissue regeneration, converting what could be considered a harmful effect (material degradation) into a beneficial healing process without requiring additional complex mechanisms
4Stability of the object's composition
If the formulation is designed to resist erosion and maintain adherence throughout treatment duration, then the formulation stability is improved, but the manufacturing precision requirements increase
Solution Approach 1:
The formulation combines water-miscible network-forming material with hydrophobic components and reinforcing members to create a composite structure that inherently resists erosion. The synergistic interaction between these components provides stability through their combined properties rather than requiring precise control of individual material characteristics, thereby reducing manufacturing precision requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation provides sustained pain relief and promotes wound healing by maintaining mechanical integrity and adherence to the extraction socket, while avoiding adverse interactions and ensuring consistent drug delivery over time.
Implementation Method 1
A pharmaceutical formulation comprises an active ingredient dispersed in a water-miscible and hygroscopic network-forming material
Implementation Method 2
which forms a cohesive matrix upon hydration
Implementation Method 3
the active ingredient dispersed within the water-miscible and hygroscopic network-forming material
Implementation Method 4
water-miscible and hygroscopic network-forming material
Data Source
AI summary
A sustained release pharmaceutical formulation for pain management comprises an active ingredient, and a water-miscible and hygroscopic network-forming material, the active ingredient being dispersed within the water-miscible and hygroscopic network-forming material. The pharmaceutical may comprise a hydrophobic component, wherein the active ingredient dispersed within the water-miscible and hygroscopic network-forming material are together dispersed in hydrophobic component. Optionally, the pharmaceutical formulation may be combined with a reinforcing member for providing a system for sustained release of the pharmaceutical formulation for pain management.